Loading…

Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?

Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistanc...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget 2015-02, Vol.6 (6), p.3519-3530
Main Authors: Williams, Michelle M, Cook, Rebecca S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53
cites cdi_FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53
container_end_page 3530
container_issue 6
container_start_page 3519
container_title Oncotarget
container_volume 6
creator Williams, Michelle M
Cook, Rebecca S
description Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies. The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis. Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways. This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing.
doi_str_mv 10.18632/oncotarget.2792
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4414133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1664777881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53</originalsourceid><addsrcrecordid>eNpVUU1P3DAQtVArWC3ce6p85BKIP2I7PYDaFVAkKi70bDnOZNdVYgfbWYl_3yxLYTvSaEaa99486SH0hZQXRAlGL4O3IZu4hnxBZU2P0ILUvC5oVbFPB_sJOkvpTzlXxaWi9TE6oZVUnCu6QP6H7QuKOzO4_gWPMWRwPmHncRPBpIxb2EIfxgF8xsa32BpvIX7DNkx9i3_NbIL3Jpxf47CFaMMAOG8gmhGm7CyOkFzKO971KfrcmT7B2dtcot-3N0-rn8XD49396vtDYbmguehUWQlhm7JrLFdGMWC1bJVUjLRd2UDTWkUF66paiVI2QrC5oaFEghDKVmyJrva649QM0NrZfTS9HqMbTHzRwTj9_8W7jV6HreaccMLYLHD-JhDD8wQp68ElC31vPIQpaSIEl1IqRWZouYfaGFKK0L2_IaV-TUp_JKV3Sc2Ur4f23gn_cmF_AXdGlEc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664777881</pqid></control><display><type>article</type><title>Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</title><source>NCBI_PubMed Central(免费)</source><creator>Williams, Michelle M ; Cook, Rebecca S</creator><creatorcontrib>Williams, Michelle M ; Cook, Rebecca S</creatorcontrib><description>Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies. The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis. Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways. This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.2792</identifier><identifier>PMID: 25784482</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Animals ; Apoptosis - physiology ; Breast - cytology ; Breast - growth &amp; development ; Breast - metabolism ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Female ; Humans ; Mammary Glands, Animal - cytology ; Mammary Glands, Animal - growth &amp; development ; Mammary Glands, Animal - metabolism ; Myeloid Cell Leukemia Sequence 1 Protein - genetics ; Myeloid Cell Leukemia Sequence 1 Protein - metabolism ; Myeloid Cell Leukemia Sequence 1 Protein - physiology ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Proto-Oncogene Proteins c-bcl-2 - physiology ; Review</subject><ispartof>Oncotarget, 2015-02, Vol.6 (6), p.3519-3530</ispartof><rights>Copyright: © 2015 Williams &amp; Cook 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53</citedby><cites>FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414133/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414133/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25784482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williams, Michelle M</creatorcontrib><creatorcontrib>Cook, Rebecca S</creatorcontrib><title>Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies. The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis. Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways. This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing.</description><subject>Animals</subject><subject>Apoptosis - physiology</subject><subject>Breast - cytology</subject><subject>Breast - growth &amp; development</subject><subject>Breast - metabolism</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Mammary Glands, Animal - cytology</subject><subject>Mammary Glands, Animal - growth &amp; development</subject><subject>Mammary Glands, Animal - metabolism</subject><subject>Myeloid Cell Leukemia Sequence 1 Protein - genetics</subject><subject>Myeloid Cell Leukemia Sequence 1 Protein - metabolism</subject><subject>Myeloid Cell Leukemia Sequence 1 Protein - physiology</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Proto-Oncogene Proteins c-bcl-2 - physiology</subject><subject>Review</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUU1P3DAQtVArWC3ce6p85BKIP2I7PYDaFVAkKi70bDnOZNdVYgfbWYl_3yxLYTvSaEaa99486SH0hZQXRAlGL4O3IZu4hnxBZU2P0ILUvC5oVbFPB_sJOkvpTzlXxaWi9TE6oZVUnCu6QP6H7QuKOzO4_gWPMWRwPmHncRPBpIxb2EIfxgF8xsa32BpvIX7DNkx9i3_NbIL3Jpxf47CFaMMAOG8gmhGm7CyOkFzKO971KfrcmT7B2dtcot-3N0-rn8XD49396vtDYbmguehUWQlhm7JrLFdGMWC1bJVUjLRd2UDTWkUF66paiVI2QrC5oaFEghDKVmyJrva649QM0NrZfTS9HqMbTHzRwTj9_8W7jV6HreaccMLYLHD-JhDD8wQp68ElC31vPIQpaSIEl1IqRWZouYfaGFKK0L2_IaV-TUp_JKV3Sc2Ur4f23gn_cmF_AXdGlEc</recordid><startdate>20150228</startdate><enddate>20150228</enddate><creator>Williams, Michelle M</creator><creator>Cook, Rebecca S</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150228</creationdate><title>Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</title><author>Williams, Michelle M ; Cook, Rebecca S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Apoptosis - physiology</topic><topic>Breast - cytology</topic><topic>Breast - growth &amp; development</topic><topic>Breast - metabolism</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Mammary Glands, Animal - cytology</topic><topic>Mammary Glands, Animal - growth &amp; development</topic><topic>Mammary Glands, Animal - metabolism</topic><topic>Myeloid Cell Leukemia Sequence 1 Protein - genetics</topic><topic>Myeloid Cell Leukemia Sequence 1 Protein - metabolism</topic><topic>Myeloid Cell Leukemia Sequence 1 Protein - physiology</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Proto-Oncogene Proteins c-bcl-2 - physiology</topic><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Williams, Michelle M</creatorcontrib><creatorcontrib>Cook, Rebecca S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, Michelle M</au><au>Cook, Rebecca S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2015-02-28</date><risdate>2015</risdate><volume>6</volume><issue>6</issue><spage>3519</spage><epage>3530</epage><pages>3519-3530</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies. The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis. Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways. This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>25784482</pmid><doi>10.18632/oncotarget.2792</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2015-02, Vol.6 (6), p.3519-3530
issn 1949-2553
1949-2553
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4414133
source NCBI_PubMed Central(免费)
subjects Animals
Apoptosis - physiology
Breast - cytology
Breast - growth & development
Breast - metabolism
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Female
Humans
Mammary Glands, Animal - cytology
Mammary Glands, Animal - growth & development
Mammary Glands, Animal - metabolism
Myeloid Cell Leukemia Sequence 1 Protein - genetics
Myeloid Cell Leukemia Sequence 1 Protein - metabolism
Myeloid Cell Leukemia Sequence 1 Protein - physiology
Proto-Oncogene Proteins c-bcl-2 - genetics
Proto-Oncogene Proteins c-bcl-2 - metabolism
Proto-Oncogene Proteins c-bcl-2 - physiology
Review
title Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T07%3A28%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bcl-2%20family%20proteins%20in%20breast%20development%20and%20cancer:%20could%20Mcl-1%20targeting%20overcome%20therapeutic%20resistance?&rft.jtitle=Oncotarget&rft.au=Williams,%20Michelle%20M&rft.date=2015-02-28&rft.volume=6&rft.issue=6&rft.spage=3519&rft.epage=3530&rft.pages=3519-3530&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.2792&rft_dat=%3Cproquest_pubme%3E1664777881%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-f80566cb0fbc48a83e397d87831df0bebdc8263f598607b663b66eb217e668c53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1664777881&rft_id=info:pmid/25784482&rfr_iscdi=true